Simple blood test could warn doctors when ovarian cancer treatment stops working
NCT ID NCT06588322
Summary
This study is testing whether a blood test can detect early signs that a specific ovarian cancer treatment is becoming less effective. Researchers will collect blood samples from 130 patients with BRCA-mutated ovarian cancer who are receiving standard maintenance therapy. The goal is to see if changes in tumor DNA in the blood can predict cancer progression months before it shows up on scans, allowing for earlier treatment adjustments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chu de Limoges
RECRUITINGLimoges, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chu de Nimes
RECRUITINGNîmes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
INSTITUT DE CANCEROLOGIE DE L'OUEST - Site Angers
RECRUITINGAngers, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
INSTITUT DE CANCEROLOGIE DE L'OUEST - Site Saint-Herblain
RECRUITINGSaint-Herblain, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
IUCT-O
RECRUITINGToulouse, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Institut Bergonie
RECRUITINGBordeaux, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.